Recent Updates
Recently added Catalysts
SNYR Positive Sentiment

Synergy CHC Announces New $20 Million Long-Term Credit Facility

Key Takeaway: Synergy CHC Corp. has announced a $20 million term loan credit agreement with ACP Agency, LLC, set to mature in May 2029. The funds will be used for debt reduction and to support the company's growth initiatives. The loan has a specified interest rate and allows for flexibility through delayed draw provisions. CEO Jack Ross expressed optimism about the refinancing, stating it enhances the company's capital structure and positions it for future strategic goals.
Price reaction · baseline $2.07 (2025-06-03 close) · hit after-hours · clean, no other SNYR news in the window
day 0 close · peak
-1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Completion of a $20 million term loan credit agreement strengthens financial stability.
  • Funds will be used to pay down debt and support growth strategies.
  • Long-term facility provides flexibility for future expansion.
  • CEO's statement reflects confidence in company's strategic direction.

Full Press Release Details

WESTBROOK, Maine, June 04, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it has entered into a $20 million term loan credit agreement, due May 2029 with ACP Agency, LLC. The proceeds will be used to pay down debt and provide the Company with growth capital.
Under the terms of the agreement, the Company received a $15 million term loan at closing, with an interest rate of SOFR plus 8.5%. The loan is interest-only through 2025, with quarterly principal payments of $175,000 beginning in January 2026, increasing to $350,000 per quarter in 2027 and beyond.
A $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility are also available to the Company.
“We are very pleased to have completed our debt refinancing, which supports our growth strategy and significantly strengthens our capital structure,” said Jack Ross, CEO of Synergy. “The long-term nature of the new facility enhances our balance sheet and provides the flexibility needed for our next phase of growth. Additionally, the delayed draw proceeds allow us to fully repay debt related to settlement agreements, positioning us for greater financial stability as we execute our strategic goals.”
About Synergy CHC Corp.
Synergy CHC Corp. is a provider of consumer health care and lifestyle products. Synergy's current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their weight management goals.
Cody Slach, Greg Robles

Frequently Asked Questions

What is the amount of Synergy's new term loan?

Synergy has entered into a term loan of $20 million.

When is the term loan due?

The term loan is due in May 2029.

What will the loan proceeds be used for?

The proceeds will reduce debt and support growth capital.

What brands does Synergy CHC Corp. offer?

Synergy offers FOCUSfactor and Flat Tummy brands.

What is FOCUSfactor known for?

FOCUSfactor is a brain health supplement that enhances memory and focus.

Last updated: Jun 4, 2025